Yesterday (4/21) the FDA announced EUA for at-home Covid testing kits from LabCorp. These nasal swab tests were previously authorized in mid-March by the FDA, however only for medical professionals to use. Stephen Hahn, FDA Commissioner, released in a statement that LabCorp and the FDA worked closely together to guarantee that testing of self-collected samples “is as safe and accurate as sample collection at a doctor’s office, hospital, or other testing site.” The testing kits will be available for patients by a doctor’s order in the coming weeks, able to ship to 46 states for $119 after also completing a survey to determine eligibility.
More on: News Regulatory